Barclays Initiates Coverage On Geron Corporation with Overweight Rating, Announces Price Target of $9.
Investment Bank Initiates Overweight Rating For Biotech Firm
Investment Bank Initiates Overweight Rating…
Investment Bank Initiates Overweight Rating For Biotech Firm
Barclays Initiates Coverage On Geron Corporation with Overweight Rating, Announces Price Target of $9.